Ariad Pharmaceuticals Inc
ARIA
ARIA was delisted on the 15th of February, 2017.
193 hedge funds and large institutions have $1.23B invested in Ariad Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 24 closing their positions.
63% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 24
38% more capital invested
Capital invested by funds: $888M → $1.23B (+$341M)
8% more funds holding
Funds holding: 179 → 193 (+14)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
5% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 62
31% less call options, than puts
Call options by funds: $19M | Put options by funds: $27.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$53.8M |
| 2 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$43.2M |
| 3 |
Renaissance Technologies
New York
|
+$17.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$15.3M |
| 5 |
Millennium Management
New York
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9.13M |
| 2 |
CCI
Columbus Circle Investors
|
-$6.91M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.88M |
| 4 |
PC
PointState Capital
New York
|
-$6.65M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.63M |
ARIA Hedge Fund Activity: Q1 2015 in Review
193 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2015, worth a combined $1.23B — up 38% from $888M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new ARIA positions and 24 closed out — a net gain of 15 holders — while 59 added to existing stakes and 62 trimmed.
The largest buyer was Putnam Investments, adding an estimated $53.8M. The largest seller was Susquehanna International Group, cutting an estimated $9.13M.
- 193 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2015, up from 179 in Q4 2014.
- Funds reported $1.23B of Ariad Pharmaceuticals Inc stock for Q1 2015, up 38% quarter-over-quarter.
- 39 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2015 and 24 closed out, a net change of +15 holders.
- The largest Ariad Pharmaceuticals Inc buyer in Q1 2015 was Putnam Investments, an estimated $53.8M added.
- The largest Ariad Pharmaceuticals Inc seller in Q1 2015 was Susquehanna International Group, an estimated $9.13M sold.
Based on aggregated 13F filings for Q1 2015.